Compared to Aluminum Hydroxide Adjuvant, Montanide ISA 206 VG Induces a Higher and More Durable Neutralizing Antibody Response against FMDV in Goats

Document Type : Original Articles

Authors

1 Medical Vaccine Department, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

2 Foot and Mouth Disease Reference Laboratory, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

3 Department of Venomous Animals and Antivenom Production, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

10.32592/ARI.2023.78.6.1843

Abstract

Foot-and-mouth disease (FMD) has a high prevalence in cloven-hoofed animals. It is also highly contagious and remains a serious threat to livestock worldwide. Despite the widespread vaccination program in Iran, outbreaks of FMD continue to occur. Vaccination is one of the most effective methods of preventing FMD. The vaccines used in Iran are of the inactivated type and contain several serotypes. Since inactivated vaccines without adjuvants do not induce a high and durable antibody response, it is necessary to use adjuvants. Montanide ISA 206 VG is a mineral oil-based adjuvant that produces a water-in-oil-in-water (w:o:w) emulsion in vaccine preparations. However, a large number of manufacturers in Iran and around the world still use alum adjuvant (with or without saponin) to produce the FMD vaccine. This study used Montanide ISA 206 and alum adjuvants to administer the O2010 serotype of the FMD virus to goats. A total of six goats were divided randomly into three groups. Vaccines were administered subcutaneously twice, at a one-month interval. Blood sampling was done at different times, and the micro-neutralization method was used to measure the neutralizing antibody titer in each serum. Seven days after the second vaccination, the alum group’s antibody titer was higher but not statistically significant. However, from the 28th day after the second injection until the end of the study, the Montanide ISA 206 group’s antibody titer was significantly higher than that of the alum group. Six months after the second injection, the antibody titer in the ISA 206 group remained at the peak level, while in the alum group, it decreased and reached the minimum protective level. Nine months after the second injection, the antibody titer remained at its peak level in the ISA 206 group, whereas it dropped significantly in the alum group. Based on the findings, ISA 206 VG is capable of generating long-term humoral immunity in goats against the FMD serotype O2010 and could replace aluminum hydroxide adjuvants in FMD vaccine preparations.

Keywords

Main Subjects

References

References
1. Grubman MJ, Baxt B. Foot-and-mouth disease. Clinical
microbiology reviews. 2004;17(2):465-93.
2. Khorasani A, Madadgar O, Soleimanjahi H, Keyvanfar
H, Mahravani H. Evaluation of the efficacy of a new
oil-based adjuvant ISA 61 VG FMD vaccine as a
potential vaccine for cattle. Iranian journal of veterinary
research. 2016;17(1):8.
3. Gadir M, Azimi S, Harzandi N, Hemati B,
Eskandarzade N. Molecular detection, genetic diversity,
and phylogenetic analysis of foot-and-mouth disease
virus (FMDV) type O in Iran during 2015-2016. Iranian
Journal of Veterinary Research. 2023;24(1):30-6.
4. Niedbalski W, Fitzner A, Bulenger K. Recent progress
in vaccines against foot-and-mouth disease. Medycyna
Weterynaryjna. 2019;75(2):1-6.
5. Park S, Kim JY, Ryu K-H, Kim A-Y, Kim J, Ko Y-J, et
al. Production of a foot-and-mouth disease vaccine
antigen using suspension-adapted BHK-21 cells in a
bioreactor. Vaccines. 2021;9(5):505.
6. Kumar A, Sharma A, Tirpude NV, Padwad Y, Hallan V,
Kumar S. Plant-derived immuno-adjuvants in vaccines
formulation: A promising avenue for improving
vaccines efficacy against SARS-CoV-2 virus.
Pharmacological Reports. 2022;74(6):1238-54.
7. Park M-E, Lee S-Y, Kim R-H, Ko M-K, Lee K-N, Kim
S-M, et al. Enhanced immune responses of foot-andmouth disease vaccine using new oil/gel adjuvant
mixtures in pigs and goats. Vaccine. 2014;32(40):5221-7.
8. Cao Y. Adjuvants for foot-and-mouth disease virus
vaccines: recent progress. Expert review of vaccines.
2014;13(11):1377-85.
9. Oleszycka E, McCluskey S, Sharp FA, Muñoz‐Wolf N,
Hams E, Gorman AL, et al. The vaccine adjuvant alum
promotes IL‐10 production that suppresses Th1
responses. European journal of immunology.
2018;48(4):705-15.
10. Hoare R, Jung S-J, Ngo TP, Bartie K, Bailey J,
Thompson KD, et al. Efficacy and safety of a nonmineral oil adjuvanted injectable vaccine for the
protection of Atlantic salmon (Salmo salar L.) against
Flavobacterium psychrophilum. Fish & shellfish
immunology. 2019;85:44-51.
11. Lyons NA, Lyoo YS, King DP, Paton DJ. Challenges of
generating and maintaining protective vaccine-induced
immune responses for foot-and-mouth disease virus in
pigs. Frontiers in veterinary science. 2016;3:102.
12. Kallel H, Jouini A, Majoul S, Rourou SJJob. Evaluation
of various serum and animal protein free media for the
production of a veterinary rabies vaccine in BHK-21
cells. 2002;95(3):195-204.
13. OIE PBJP, France. NB: Version adapted by the World
Assembly of Delegates of the Office International des
epizooties. 2009.
14.Rweyemamu MM, Booth JC, Head M, Pay TWJE,
Infection. Microneutralization tests for serological
typing and subtyping of foot-and-mouth disease virus
strains. 1978;81(1):107-23.
15. Kärber G. Beitrag zur kollektiven Behandlung
pharmakologischer Reihenversuche. NaunynSchmiedebergs Archiv für experimentelle pathologie
und pharmakologie. 1931;162:480-3.
16.Bazid A-HI, El-Alfy HA, El-Didamony G, Elfeil WK,
El-Sayed MM, Fawzy M. Adjuvant effect of saponin in
an oil-based monovalent (serotype O) foot-and-mouth
disease virus vaccine on the antibody response in guinea
pigs and cattle. Archives of Virology. 2021;166:1977-84.
17.Ibrahim EE-S, Gamal WM, Hassan AI, Mahdy SE-D,
Hegazy AZ, Abdel-Atty MM. Comparative study on the
immunopotentiator effect of ISA 201, ISA 61, ISA 50,
ISA 206 used in trivalent foot and mouth disease
vaccine. Veterinary world. 2015;8(10):1189.
18. Pay T, Hingley P. A potency test method for foot and
mouth disease vaccine based on the serum neutralizing
antibody response produced in cattle. Vaccine.
1992;10(10):707-13.
19. Lu Z, Yu S, Wang W, Chen W, Wang X, Wu K, et al.
Development of Foot-and-Mouth Disease Vaccines in
Taghizadeh M et al / Archives of Razi Institute, Vol. 78, No. 6 (2023) 1843-1851 1851
Recent Years. 2022;10(11):1817.
20.Jiang H, Wang Q, Li L, Zeng Q, Li H, Gong T, et al.
Turning the old adjuvant from gel to nanoparticles to
amplify CD8+ T cell responses. 2018;5(1):1700426.
21. Marciani DJJTiPS. Elucidating the mechanisms of
action of saponin-derived adjuvants. 2018;39(6):573-85.
22. Grubman M, Baxt BJARS. Foot-and-Mouth Disease,
clinical microbiology reviews. 17 (2). 465–493. 2004.
23. Khorasani A, Madadgar O, Soleimanjahi H, Keyvanfar
H, Mahravani HJIjovr. Evaluation of the efficacy of a
new oil-based adjuvant ISA 61 VG FMD vaccine as a
potential vaccine for cattle. 2016;17(1):8.
24.Bazid A-H, Amer HM, Nayel M, Attia M, Maklad N,
Wasfy M, et al. Assessment of the potency and
effectiveness of a heptavalent oil-adjuvanted (ISA 206)
foot-and-mouth disease vaccine in Egypt. Archives of
Virology. 2023;168(2):1-8.
Archives of Razi Institute
Volume 78, Issue 6
November and December 2023
Pages 1843-1851

Files

Share

How to cite

Statistics